EMEA (Europe, Middle East and Africa) Gabapentin Market Report 2018

January 2018 | 102 pages | ID: E8647CD378AEN
QYResearch

Abstracts

In this report, the EMEA Gabapentin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Gabapentin for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Gabapentin market competition by top manufacturers/players, with Gabapentin sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• GSK
• Sailike
• Jiangsu Enhua
• Jiangsu Hengrui
• Novartis
• Actavis
• Glenmark

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Tablet
• Capsule

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Nerve Pain
• Restless Legs Syndrome
• Seizures

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Gabapentin Market Report 2017

1 GABAPENTIN OVERVIEW

1.1 Product Overview and Scope of Gabapentin
1.2 Classification of Gabapentin
  1.2.1 EMEA Gabapentin Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Gabapentin Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Capsule
1.3 EMEA Gabapentin Market by Application/End Users
  1.3.1 EMEA Gabapentin Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Nerve Pain
  1.3.3 Restless Legs Syndrome
  1.3.4 Seizures
1.4 EMEA Gabapentin Market by Region
  1.4.1 EMEA Gabapentin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Gabapentin (2012-2022)
  1.5.1 EMEA Gabapentin Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Gabapentin Revenue and Growth Rate (2012-2022)

2 EMEA GABAPENTIN COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Gabapentin Market Competition by Players/Manufacturers
  2.1.1 EMEA Gabapentin Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Gabapentin Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Gabapentin Sale Price by Players (2012-2017)
2.2 EMEA Gabapentin (Volume and Value) by Type/Product Category
  2.2.1 EMEA Gabapentin Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Gabapentin Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Gabapentin Sale Price by Type (2012-2017)
2.3 EMEA Gabapentin (Volume) by Application
2.4 EMEA Gabapentin (Volume and Value) by Region
  2.4.1 EMEA Gabapentin Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Gabapentin Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Gabapentin Sales Price by Region (2012-2017)

3 EUROPE GABAPENTIN (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Gabapentin Sales and Value (2012-2017)
  3.1.1 Europe Gabapentin Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Gabapentin Revenue and Growth Rate (2012-2017)
3.2 Europe Gabapentin Sales and Market Share by Type
3.3 Europe Gabapentin Sales and Market Share by Application
3.4 Europe Gabapentin Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Gabapentin Sales Volume by Countries (2012-2017)
  3.4.2 Europe Gabapentin Revenue by Countries (2012-2017)
  3.4.3 Germany Gabapentin Sales and Growth Rate (2012-2017)
  3.4.4 France Gabapentin Sales and Growth Rate (2012-2017)
  3.4.5 UK Gabapentin Sales and Growth Rate (2012-2017)
  3.4.6 Russia Gabapentin Sales and Growth Rate (2012-2017)
  3.4.7 Italy Gabapentin Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Gabapentin Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GABAPENTIN (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Gabapentin Sales and Value (2012-2017)
  4.1.1 Middle East Gabapentin Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Gabapentin Revenue and Growth Rate (2012-2017)
4.2 Middle East Gabapentin Sales and Market Share by Type
4.3 Middle East Gabapentin Sales and Market Share by Application
4.4 Middle East Gabapentin Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Gabapentin Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Gabapentin Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Gabapentin Sales and Growth Rate (2012-2017)
  4.4.4 Israel Gabapentin Sales and Growth Rate (2012-2017)
  4.4.5 UAE Gabapentin Sales and Growth Rate (2012-2017)
  4.4.6 Iran Gabapentin Sales and Growth Rate (2012-2017)

5 AFRICA GABAPENTIN (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Gabapentin Sales and Value (2012-2017)
  5.1.1 Africa Gabapentin Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Gabapentin Revenue and Growth Rate (2012-2017)
5.2 Africa Gabapentin Sales and Market Share by Type
5.3 Africa Gabapentin Sales and Market Share by Application
5.4 Africa Gabapentin Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Gabapentin Sales Volume by Countries (2012-2017)
  5.4.2 Africa Gabapentin Revenue by Countries (2012-2017)
  5.4.3 South Africa Gabapentin Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Gabapentin Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Gabapentin Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Gabapentin Sales and Growth Rate (2012-2017)

6 EMEA GABAPENTIN MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gabapentin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Gabapentin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sailike
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Gabapentin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Jiangsu Enhua
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Gabapentin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Jiangsu Hengrui
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Gabapentin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Gabapentin Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Actavis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Gabapentin Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Actavis Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Glenmark
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Gabapentin Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 GABAPENTIN MANUFACTURING COST ANALYSIS

7.1 Gabapentin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gabapentin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gabapentin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gabapentin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GABAPENTIN MARKET FORECAST (2017-2022)

11.1 EMEA Gabapentin Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Gabapentin Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Gabapentin Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Gabapentin Price and Trend Forecast (2017-2022)
11.2 EMEA Gabapentin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Gabapentin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Gabapentin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Gabapentin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Gabapentin Sales Forecast by Type (2017-2022)
11.7 EMEA Gabapentin Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gabapentin
Figure EMEA Gabapentin Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Gabapentin Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Capsule Product Picture
Figure EMEA Gabapentin Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Gabapentin by Application in 2016
Figure Nerve Pain Examples
Table Key Downstream Customer in Nerve Pain
Figure Restless Legs Syndrome Examples
Table Key Downstream Customer in Restless Legs Syndrome
Figure Seizures Examples
Table Key Downstream Customer in Seizures
Figure EMEA Gabapentin Market Size (Million USD) by Region (2012-2022)
Figure Europe Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gabapentin Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Gabapentin Revenue (Million USD) Status and Forecast by Countries
Figure Africa Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Gabapentin Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Gabapentin Sales Volume and Growth Rate (2012-2022)
Figure EMEA Gabapentin Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Gabapentin Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Gabapentin Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Gabapentin Sales Share by Players (2012-2017)
Figure 2016 Gabapentin Sales Share by Players
Figure 2017 Gabapentin Sales Share by Players
Figure EMEA Gabapentin Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Gabapentin Revenue (Million USD) by Players (2012-2017)
Table EMEA Gabapentin Revenue Share by Players (2012-2017)
Table 2016 EMEA Gabapentin Revenue Share by Players
Table 2017 EMEA Gabapentin Revenue Share by Players
Table EMEA Gabapentin Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Gabapentin Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Gabapentin Sales Share by Type (2012-2017)
Figure Sales Market Share of Gabapentin by Type (2012-2017)
Figure EMEA Gabapentin Sales Market Share by Type (2012-2017)
Table EMEA Gabapentin Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Gabapentin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gabapentin by Type in 2016
Table EMEA Gabapentin Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Gabapentin Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Gabapentin Sales Share by Application (2012-2017)
Figure Sales Market Share of Gabapentin by Application (2012-2017)
Figure EMEA Gabapentin Sales Market Share by Application in 2016
Table EMEA Gabapentin Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Gabapentin Sales Share by Region (2012-2017)
Figure Sales Market Share of Gabapentin by Region (2012-2017)
Figure EMEA Gabapentin Sales Market Share in 2016
Table EMEA Gabapentin Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Gabapentin Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Gabapentin by Region (2012-2017)
Figure EMEA Gabapentin Revenue Market Share Regions in 2016
Table EMEA Gabapentin Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Gabapentin Revenue and Growth Rate (2012-2017)
Table Europe Gabapentin Sales (K Units) by Type (2012-2017)
Table Europe Gabapentin Market Share by Type (2012-2017)
Figure Europe Gabapentin Market Share by Type in 2016
Table Europe Gabapentin Sales (K Units) by Application (2012-2017)
Table Europe Gabapentin Market Share by Application (2012-2017)
Figure Europe Gabapentin Market Share by Application in 2016
Table Europe Gabapentin Sales (K Units) by Countries (2012-2017)
Table Europe Gabapentin Sales Market Share by Countries (2012-2017)
Figure Europe Gabapentin Sales Market Share by Countries (2012-2017)
Figure Europe Gabapentin Sales Market Share by Countries in 2016
Table Europe Gabapentin Revenue (Million USD) by Countries (2012-2017)
Table Europe Gabapentin Revenue Market Share by Countries (2012-2017)
Figure Europe Gabapentin Revenue Market Share by Countries (2012-2017)
Figure Europe Gabapentin Revenue Market Share by Countries in 2016
Figure Germany Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure France Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure UK Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Gabapentin Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Gabapentin Sales (K Units) by Type (2012-2017)
Table Middle East Gabapentin Market Share by Type (2012-2017)
Figure Middle East Gabapentin Market Share by Type (2012-2017)
Table Middle East Gabapentin Sales (K Units) by Applications (2012-2017)
Table Middle East Gabapentin Market Share by Applications (2012-2017)
Figure Middle East Gabapentin Sales Market Share by Application in 2016
Table Middle East Gabapentin Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Gabapentin Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Gabapentin Sales Volume Market Share by Countries in 2016
Table Middle East Gabapentin Revenue (Million USD) by Countries (2012-2017)
Table Middle East Gabapentin Revenue Market Share by Countries (2012-2017)
Figure Middle East Gabapentin Revenue Market Share by Countries (2012-2017)
Figure Middle East Gabapentin Revenue Market Share by Countries in 2016
Figure Saudi Arabia Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Gabapentin Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Gabapentin Sales (K Units) by Type (2012-2017)
Table Africa Gabapentin Sales Market Share by Type (2012-2017)
Figure Africa Gabapentin Sales Market Share by Type (2012-2017)
Figure Africa Gabapentin Sales Market Share by Type in 2016
Table Africa Gabapentin Sales (K Units) by Application (2012-2017)
Table Africa Gabapentin Sales Market Share by Application (2012-2017)
Figure Africa Gabapentin Sales Market Share by Application (2012-2017)
Table Africa Gabapentin Sales Volume (K Units) by Countries (2012-2017)
Table Africa Gabapentin Sales Market Share by Countries (2012-2017)
Figure Africa Gabapentin Sales Market Share by Countries (2012-2017)
Figure Africa Gabapentin Sales Market Share by Countries in 2016
Table Africa Gabapentin Revenue (Million USD) by Countries (2012-2017)
Table Africa Gabapentin Revenue Market Share by Countries (2012-2017)
Figure Africa Gabapentin Revenue Market Share by Countries (2012-2017)
Figure Africa Gabapentin Revenue Market Share by Countries in 2016
Figure South Africa Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Gabapentin Basic Information List
Table Pfizer Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Gabapentin Sales Market Share in EMEA (2012-2017)
Figure Pfizer Gabapentin Revenue Market Share in EMEA (2012-2017)
Table GSK Gabapentin Basic Information List
Table GSK Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Gabapentin Sales Market Share in EMEA (2012-2017)
Figure GSK Gabapentin Revenue Market Share in EMEA (2012-2017)
Table Sailike Gabapentin Basic Information List
Table Sailike Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sailike Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Sailike Gabapentin Sales Market Share in EMEA (2012-2017)
Figure Sailike Gabapentin Revenue Market Share in EMEA (2012-2017)
Table Jiangsu Enhua Gabapentin Basic Information List
Table Jiangsu Enhua Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Jiangsu Enhua Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Jiangsu Enhua Gabapentin Sales Market Share in EMEA (2012-2017)
Figure Jiangsu Enhua Gabapentin Revenue Market Share in EMEA (2012-2017)
Table Jiangsu Hengrui Gabapentin Basic Information List
Table Jiangsu Hengrui Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Jiangsu Hengrui Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Jiangsu Hengrui Gabapentin Sales Market Share in EMEA (2012-2017)
Figure Jiangsu Hengrui Gabapentin Revenue Market Share in EMEA (2012-2017)
Table Novartis Gabapentin Basic Information List
Table Novartis Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Gabapentin Sales Market Share in EMEA (2012-2017)
Figure Novartis Gabapentin Revenue Market Share in EMEA (2012-2017)
Table Actavis Gabapentin Basic Information List
Table Actavis Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Actavis Gabapentin Sales Market Share in EMEA (2012-2017)
Figure Actavis Gabapentin Revenue Market Share in EMEA (2012-2017)
Table Glenmark Gabapentin Basic Information List
Table Glenmark Gabapentin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glenmark Gabapentin Sales (K Units) and Growth Rate (2012-2017)
Figure Glenmark Gabapentin Sales Market Share in EMEA (2012-2017)
Figure Glenmark Gabapentin Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gabapentin
Figure Manufacturing Process Analysis of Gabapentin
Figure Gabapentin Industrial Chain Analysis
Table Raw Materials Sources of Gabapentin Major Manufacturers in 2016
Table Major Buyers of Gabapentin
Table Distributors/Traders List
Figure EMEA Gabapentin Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Gabapentin Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Gabapentin Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Gabapentin Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Gabapentin Sales Market Share Forecast by Region (2017-2022)
Table EMEA Gabapentin Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Gabapentin Revenue Market Share Forecast by Region (2017-2022)
Table Europe Gabapentin Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Gabapentin Sales Market Share Forecast by Countries (2017-2022)
Table Europe Gabapentin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Gabapentin Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Gabapentin Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Gabapentin Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Gabapentin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Gabapentin Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Gabapentin Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Gabapentin Sales Market Share Forecast by Countries (2017-2022)
Table Africa Gabapentin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Gabapentin Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Gabapentin Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Gabapentin Sales Market Share Forecast by Type (2017-2022)
Table EMEA Gabapentin Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Gabapentin Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources